Primary antibodies against HIF-1 (610958, BD Biosciences, Franklin Lakes, NJ), hydroxy-HIF-1 (3434, Cell Signaling Technology, Danvers, MA), HIF-2 (NB100-122, Novus Biologicals, Littleton, CO), TOM20 (11802-1-AP, Proteintech Group, Rosemont, IL), HSP60 (15282-1-AP, Proteintech Group), and Tubulin (sc-8035, Santa Cruz Biotechnology, Dallas, TX) were diluted in blocking buffer and incubated overnight at 4 C
#14 Cartaphilus":oydj6ojj said: Here's one I made a while back if it helps
()
Clin Transl Med 2022;12:e902
Varenicline interactions may also occur with nicotine replacement therapy and alcohol
Fear of plain packaging The new EU provisions might only be the tip of the iceberg